Deeks SG - Search Results

1

Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response.

Deeks SG, Grant RM, Wrin T, Paxinos EE, Liegler T, Hoh R, Martin JN, Petropoulos CJ. Deeks SG, et al. AIDS. 2003 Feb 14;17(3):361-70. doi: 10.1097/00002030-200302140-00010. AIDS. 2003. PMID: 12556690

2

Genotypic-resistance assays and antiretroviral therapy.

Deeks SG, Abrams DI. Deeks SG, et al. Lancet. 1997 May 24;349(9064):1489-90. doi: 10.1016/S0140-6736(05)62092-2. Lancet. 1997. PMID: 9167453 No abstract available.

3

HIV-1 protease inhibitors.

Deeks SG, Volberding PA. Deeks SG, et al. AIDS Clin Rev. 1997-1998:145-85. doi: 10.1001/jama.1997.03540260059037. AIDS Clin Rev. 1997. PMID: 9305448 Review. No abstract available.

4

Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure.

Deeks SG, Grant RM, Beatty GW, Horton C, Detmer J, Eastman S. Deeks SG, et al. AIDS. 1998 Jul 9;12(10):F97-102. doi: 10.1097/00002030-199810000-00002. AIDS. 1998. PMID: 9677159

5

Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans.

Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Deeks S, McCune JM. Hellerstein M, et al. Nat Med. 1999 Jan;5(1):83-9. doi: 10.1038/4772. Nat Med. 1999. PMID: 9883844

6

Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome.

Deeks SG, Hellmann NS, Grant RM, Parkin NT, Petropoulos CJ, Becker M, Symonds W, Chesney M, Volberding PA. Deeks SG, et al. J Infect Dis. 1999 Jun;179(6):1375-81. doi: 10.1086/314775. J Infect Dis. 1999. PMID: 10228057 Clinical Trial.

7

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.

Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM. Deeks SG, et al. AIDS. 1999 Apr 16;13(6):F35-43. doi: 10.1097/00002030-199904160-00001. AIDS. 1999. PMID: 10397555

8

Factors influencing T-cell turnover in HIV-1-seropositive patients.

McCune JM, Hanley MB, Cesar D, Halvorsen R, Hoh R, Schmidt D, Wieder E, Deeks S, Siler S, Neese R, Hellerstein M. McCune JM, et al. J Clin Invest. 2000 Mar;105(5):R1-8. doi: 10.1172/JCI8647. J Clin Invest. 2000. PMID: 10712441 Free PMC article.

9

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection.

Deeks SG, Barbour JD, Martin JN, Swanson MS, Grant RM. Deeks SG, et al. J Infect Dis. 2000 Mar;181(3):946-53. doi: 10.1086/315334. J Infect Dis. 2000. PMID: 10720517

10

Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy.

Huang SS, Barbour JD, Deeks SG, Huang JS, Grant RM, Ng VL, McCune JM. Huang SS, et al. Among authors: deeks sg. Clin Infect Dis. 2000 Mar;30(3):504-10. doi: 10.1086/313714. Clin Infect Dis. 2000. PMID: 10722435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

691 results

Search Page

Filters